Probiotic Clinical

There are literally thousands of probiotic species of flora available to manufacturers (and consumers). Some are effective, some are not. Some ezymes work effectively across animal groups, while others only work in one specific organism e.g. dog, cat, or human).

There have been numerous clinical trials on different probiotics, however almost all species have had little or no well designed clinical trials proving any benefit. A few species have been demonstrated in multiple clinical trials to be effective in preventing and treating multiple conditions.

Even fewer species have any clinical evidence to substantiate their safety, efficacy, stability, dose, implantation rate or colonization rate.  All these factors have an influence on the quality and the effectiveness of any probiotic.
For over 99% of probiotics, the combination of low survivability to your home, low survivability in your body, dismal implantation and activation rates, short time for implantation and lack of clinical proof, leads us to conclude they are at worst overwhelmingly over hyped and overpriced and at best ineffective.

Lactobacillus acidophilus was the probiotic of choice for several years due to its ease of manufacture and relatively low price. However, the effectiveness of treatment with this species is at best uncertain. It has been reported that some probiotic supplements claiming to have viable cells of Lactobacillus acidophilus present in large numbers (billions) actually have very low numbers (hundreds). This most likely is due to the species inherent fragility, which science has not yet discovered how to effectively overcome.

When we set out to formulate Fiberrific +probiotic, we took into account all of these factors. After reviewing hundreds of probiotic species for clinical proof, we ended up with only one species that had abundant clinical evidence to substantiate all the claims, the one we chose, Lactobacillus sporogenes.

Lactobacillus sporogenes has undergone extensive clinical testing. In human trials it was found to resolve intestinal catarrh, diarrhoea, constipation, abdominal pain, vomiting, nausea, allergic skin disease, jaundice, septicaemia, vaginitis and ulcers. This specific probiotic is also effective in treating cholesterol. Lactobacillus sporogenes in clinical trials assisted in reducing total cholesterol by 30%, LDL (bad cholesterol) by 20% and increasing HDL (good cholesterol) by 7%.

Once we had our probiotic, we needed to enhance it to make it even better. Simply being the pest species was not enough! We decided to add Lactobacillus sporogenes to the best supplement on the market, Fiberrific.

Fiberrific is unique in its ability to enhance probiotics. Fiberrific is not only an excellent source of fiber (over 97% fiber with no taste or texture), it is also classified as a prebiotic.

Unlike probiotics, prebiotics don't replace bacteria but help feed up the 'good' bacteria in the digestive tract enabling them to act faster, act better and act longer.

The combination of Lactobacillus sporogenes and Fiberrific, known as Fiberrific +probiotic, is the complete solution - a potent shelf-stable probiotic, an effective prebiotic and a highly effective fiber all in one pleasant tasting, easy to use product. What could be better?

Back to Chart